PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9626567-4	1998	Cells with high-level expression of human G6PD were 2.3 (H6) to 3.7 (H7) times more resistant to TBH than control cells.	tert-Butylhydroperoxide	97-100	glucose-6-phosphate dehydrogenase	Homo sapiens	42-46	
9626567-9	1998	In this study, overexpression of human G6PD in NIH3T3 cells had different effects on the toxicity of TBH vs. paraquat.	tert-Butylhydroperoxide	101-104	glucose-6-phosphate dehydrogenase	Homo sapiens	39-43	
8496623-9	1993	The activity of glucose-6-phosphate dehydrogenase was decreased 50% following treatment for 5 h with 700 microM CHP or tBHP, whereas H2O2 treatment caused a brief 15% decline, followed by recovery.	tert-Butylhydroperoxide	119-123	glucose-6-phosphate dehydrogenase	Homo sapiens	16-49	
2015106-2	1991	Exposure to tert-butylhydroperoxide induced, most markedly in G6PD- and PK-deficient erythrocytes, a reduction of protein bands 1, 2, 2.1, 3, 4.1, 4.2, and 5, with the appearance of high-molecular-weight aggregates and of "new" polypeptide components in the 29- to 23-kDa region and with a marked increase of membrane-bound globin.	tert-Butylhydroperoxide	12-35	glucose-6-phosphate dehydrogenase	Homo sapiens	62-74	
18702879-7	2008	The oxidative action induced by TBHP was observed in erythrocytes AA<AS<SS, by the increase in the content of Heinz bodies, methemoglobin, hemolysis, GSH depletion and lowering activities of the enzymes G6-PD and GR.	tert-Butylhydroperoxide	32-36	glucose-6-phosphate dehydrogenase	Homo sapiens	209-214	
3673705-6	1987	The stimulation of flux through the pentose phosphate pathway during the metabolism of t-butyl hydroperoxide is presented, and the increase in cellular activity of glucose-6-phosphate dehydrogenase is correlated with the increase in the level of protSSG.	tert-Butylhydroperoxide	87-108	glucose-6-phosphate dehydrogenase	Homo sapiens	164-197